These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36198355)

  • 1. Short-term rapamycin treatment increases life span and attenuates aortic aneurysm in a murine model of Marfan-Syndrome.
    Zaradzki M; Mohr F; Lont S; Soethoff J; Remes A; Arif R; Müller OJ; Karck M; Hecker M; Wagner AH
    Biochem Pharmacol; 2022 Nov; 205():115280. PubMed ID: 36198355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome.
    Xiong W; Knispel RA; Dietz HC; Ramirez F; Baxter BT
    J Vasc Surg; 2008 Jan; 47(1):166-72; discussion 172. PubMed ID: 18178469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV-mediated AP-1 decoy oligonucleotide expression inhibits aortic elastolysis in a mouse model of Marfan syndrome.
    Remes A; Arif R; Franz M; Jungmann A; Zaradzki M; Puehler T; Heckmann MB; Frey N; Karck M; Kallenbach K; Hecker M; Müller OJ; Wagner AH
    Cardiovasc Res; 2021 Nov; 117(12):2459-2473. PubMed ID: 33471064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox Dysregulation of Vascular Smooth Muscle Sirtuin-1 in Thoracic Aortic Aneurysm in Marfan Syndrome.
    Budbazar E; Sulser Ponce De Leon S; Tsukahara Y; Liu H; Huangfu Y; Wang Y; Seabra PM; Yang X; Goodman JB; Wan X; Chitalia V; Han J; Seta F
    Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):e339-e357. PubMed ID: 37288573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Notch3 Activation on Aortic Aneurysm Development in Marfan Syndrome.
    Jespersen K; Li C; Batra R; Stephenson CA; Harding P; Sestak K; Foley RT; Greene H; Meisinger T; Cook JR; Baxter BT; Xiong W
    J Immunol Res; 2022; 2022():7538649. PubMed ID: 35211631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics reveals Rictor as a noncanonical TGF-β signaling target during aneurysm progression in Marfan mice.
    Parker SJ; Stotland A; MacFarlane E; Wilson N; Orosco A; Venkatraman V; Madrid K; Gottlieb R; Dietz HC; Van Eyk JE
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1112-H1126. PubMed ID: 30004239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Fat Diet Has a Protective Sex-Dependent Effect on Aortic Aneurysm Severity in a Marfan Syndrome Mouse Model.
    Lau C; Muthu ML; Siddiqui IF; Li L; Reinhardt DP
    Can J Cardiol; 2023 Nov; 39(11):1553-1567. PubMed ID: 37482239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome.
    Ju X; Ijaz T; Sun H; Lejeune W; Vargas G; Shilagard T; Recinos A; Milewicz DM; Brasier AR; Tilton RG
    J Am Heart Assoc; 2014 Jan; 3(1):e000476. PubMed ID: 24449804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
    Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
    Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
    Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome.
    Nistala H; Lee-Arteaga S; Carta L; Cook JR; Smaldone S; Siciliano G; Rifkin AN; Dietz HC; Rifkin DB; Ramirez F
    Hum Mol Genet; 2010 Dec; 19(24):4790-8. PubMed ID: 20871099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model.
    Hibender S; Franken R; van Roomen C; Ter Braake A; van der Made I; Schermer EE; Gunst Q; van den Hoff MJ; Lutgens E; Pinto YM; Groenink M; Zwinderman AH; Mulder BJ; de Vries CJ; de Waard V
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1618-26. PubMed ID: 27283746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitro-oleic acid reduces thoracic aortic aneurysm progression in a mouse model of Marfan syndrome.
    Nettersheim FS; Lemties J; Braumann S; Geißen S; Bokredenghel S; Nies R; Hof A; Winkels H; Freeman BA; Klinke A; Rudolph V; Baldus S; Mehrkens D; Mollenhauer M; Adam M
    Cardiovasc Res; 2022 Jul; 118(9):2211-2225. PubMed ID: 34324651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrillin-1-regulated miR-122 has a critical role in thoracic aortic aneurysm formation.
    Zhang RM; Tiedemann K; Muthu ML; Dinesh NEH; Komarova S; Ramkhelawon B; Reinhardt DP
    Cell Mol Life Sci; 2022 May; 79(6):314. PubMed ID: 35606547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lineage-Specific Induced Pluripotent Stem Cell-Derived Smooth Muscle Cell Modeling Predicts Integrin Alpha-V Antagonism Reduces Aortic Root Aneurysm Formation in Marfan Syndrome Mice.
    Nakamura K; Dalal AR; Yokoyama N; Pedroza AJ; Kusadokoro S; Mitchel O; Gilles C; Masoudian B; Leipzig M; Casey KM; Hiesinger W; Uchida T; Fischbein MP
    Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1134-1153. PubMed ID: 37078287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMP-2 regulates Erk1/2 phosphorylation and aortic dilatation in Marfan syndrome.
    Xiong W; Meisinger T; Knispel R; Worth JM; Baxter BT
    Circ Res; 2012 Jun; 110(12):e92-e101. PubMed ID: 22550139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome.
    Emrich FC; Okamura H; Dalal AR; Penov K; Merk DR; Raaz U; Hennigs JK; Chin JT; Miller MO; Pedroza AJ; Craig JK; Koyano TK; Blankenberg FG; Connolly AJ; Mohr FW; Alvira CM; Rabinovitch M; Fischbein MP
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):146-54. PubMed ID: 25359856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Endothelial Barrier in Marfan Mice (mgR/mgR) Results in Severe Inflammation after Adenoviral Gene Therapy.
    Seppelt PC; Schwill S; Weymann A; Arif R; Weber A; Zaradzki M; Richter K; Ensminger S; Robinson PN; Wagner AH; Karck M; Kallenbach K
    PLoS One; 2016; 11(2):e0148012. PubMed ID: 26840980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FN (Fibronectin)-Integrin α5 Signaling Promotes Thoracic Aortic Aneurysm in a Mouse Model of Marfan Syndrome.
    Chen M; Cavinato C; Hansen J; Tanaka K; Ren P; Hassab A; Li DS; Youshao E; Tellides G; Iyengar R; Humphrey JD; Schwartz MA
    Arterioscler Thromb Vasc Biol; 2023 May; 43(5):e132-e150. PubMed ID: 36994727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-29b participates in early aneurysm development in Marfan syndrome.
    Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
    Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.